Please assess the completion status of the following clinical trial:

Trial Title: Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* HIV uninfected~* Acceptable methods of contraception for females of reproductive potential~* Good general health~* Signed written inform consent~Exclusion Criteria:~* Risk to be infected by HIV virus~* Uveitis, chronic lyme disease, active syphilis, active mycobacterial diseases or sarcoidosis~* Autoimmune disease or immunodeficiency~* Medical history of food allergy, Lyell's or Steven Johnson's disease, unstable asthma~* Active, generalized eczema or chronic urticaria~* Blood products within 2 months prior to first study vaccine administration~* HIV vaccines in prior HIV vaccine trial or participation in an immunomodulator study~* Vaccines within 30 days prior to first study vaccine administration~* Pregnant~* Long-term immunosuppressive or immunomodulator medications or within 6 months to first study vaccine administration~* Blood transfusion within 6 months to first study vaccine administration~* Treated with extracted pituitary hormones

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).